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THE STRATEGY OF RNA VIRUSES*
DAVID BALTIMORE
Department of Biology and Center for Cancer Research,
Massachusetts Institute of Technology,
Cambridge, Massachusetts
I. INTRODUCTION

I

N this presentation I shall contrast three types of animal viruses that
in their extracellular state appear very similar, but as replicating
viruses are very different. The three types of viruses are: picornaviruses,
typified by poliovirus; rhabdoviruses, typified by vesicular stomatitis
virus (VSV), and RNA tumor viruses.
The virions of all three of these viruses contain a single strand of RNA
which is 2.5 to_ 4 X 106 daltons in length (on the order of 10 kilobases).
While these viruses _might appear superficially similar because of the
similarity of their genome structure, there are enormous differences in
the modes of nucleic acid synthesis used by the viruses, the organiza
tion of their messenger RNA (mRNA), the types of polymerases in
volved in replicating them, and the way in which they utilize the
hospitality of the host cell.
Although many experimental observations have contributed to our
understanding of these viruses, generally a single experiment provided
the clue that signaled the unique features of a given virus. In what
follows, the key observation for each of the systems will be discussed,
and later work on the properties of the virus will then be summarized.
The work from my laboratory described here was often performed by
graduate students, postdoctoral fellows, or my close associate Donna
Smoler. The names of my other principal associates are: for poliovirus
work Michael Jacobson, Charles Cole, Deborah Spector, Martinez
Hewlett, Lydia Villa-Komaroff, and Harvey Lodish; for VSV work,
Alice Huang, Martha Stampfer, John Rose, David Knipe, and Harvey
Lodish; and for RNA tumor virus work, Inder Verma, Amos Panet, and
William Haseltine.
*Lecture delivered January 16, 1975.
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II. POLIOVIRUS
The key observation to our understanding of the life strategy used by
the poliovirus genome was the observation many years ago that polio
virus RNA is infectious (Colter et al., 1957; Alexander et al., 1958). At
the time that observation was made, it merely confirmed what was
known with tobacco mosaic virus, but the further development of
animal virology has shown that only a few classes of viruses have
infectious RNAs.
The existence of an infectious RNA implies that the RNA polymerase
that replicates the RNA is either present in the uninfected cell or is
specified directly by the incoming RNA acting as a mRNA. Because no
polymerase able to replicate poliovirus RNA has ever been identified in
uninfected cells, we have come to believe that at least a critical subunit
of the poliovirus replicase is encoded by the viral RNA. A new replicase
activity has been identified in the cytoplasm of poliovirus-infected cells
(Baltimore et al., 1963)-this is the only evidence for a virus-specific
subunit.
Another approach to understanding the poliovirus strategy is to ask
whether its virion RNA can act as mRNA. Before showing how we
know that poliovirus RNA is a mRNA for the synthesis of the viral
proteins, we first must introduce a variant of poliovirus called the
poliovirus defective interfering particle, or "polio DI" for short.
Polio DI is a deletion mutant of poliovirus which appeared in our
stocks as a contaminant and can be purified away from standard
poliovirus because the DI virion has a lower density than the standard
virion (Cole et al., 1971). The RNA of DI is smaller than standard RNA
based on its migration rate during electrophoresis (Fig. 1), its sedi
mentation rate in sucrose gradients and competitive hybridization
studies (Cole and Baltimore, 1973). Poliovirus makes a double-stranded
RNA also called "replicative form" or RF (Baltimore et al., 1964;
Baltimore, 1966); an easy way to show that polio DI is a deletion is to
measure the length of the standard and DI double-stranded RNAs.
From electron micrographs of the double-stranded RNAs, histograms of
the lengths of standard and DI RNA have been constructed (Fig. 2).
They indicate a difference of 15-20% in the length of the two RNA
molecules.
Before turning to the question of whether virion RNA can act as
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FIG. 1. Comparison of the electrophoretic mobility of standard (- - -•) and
DI (o--o) RNA in polyacrylamide gels. Standard poliovirion RNA labeled with
14
[
C] uridine was mixed with the RNA from DI particles labeled with [ 3 H] uri
dine. The two RNAs were analyzed by electrophoresis through 2.6% polyacryl
amide gels. Migration was from left to right. Reprinted from Cole et al. (1971) by
permission of the publisher.

mRNA the peculiar nature of poliovirus-specific protein synthesis must
be understood. While a large number of discrete polypeptides can be
found in the cytoplasm of poliovirus-infected cells, evidence from
various types of experiments points to the existence of only a single,
long polypeptide (really a polyprotein) as the translation product of the
poliovirus genome. This was initially demonstrated in a study of the
sizes of the poliovirus proteins made when amino acid analogs replaced
certain of the standard amino acids in the growth medium (Jacobson
and Baltimore, 1968). A series of long polypeptides were found, the.
longest of which was the appropriate size to be a total transcript of the
poliovirus genome (Jacobson et al., 1970). We have more recently been
able to prove that this is a transcript of the whole genome by looking at
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FIG. 2. Comparison of the sizes of double-stranded RNA of (A) standard
poliovirus and (B) DI particles. The lengths of poliovirus double-stranded RNA
molecules (RF RNA) were determined by electron microscopy. Unpublished data
of Dr. M. Hewlett.

the size of this protein in cells infected by standard virus and in cells
infected by polio DI (Cole and Baltimore, 1973). Figure 3 represents
coelectrophoresis of the virus-specific proteins in cells infected by
either standard virus or polio DI and incubated in the presence of
amino acid analogs. The largest product (marked NCVP-00) is slightly
shorter in the DI-infected cells ("DI(1) NCVP-00") than in the standard
virus-infected cells, and calculations indicate that the loss of protein
corresponds to about 15% of the total genome ( Cole and Baltimore,
1973). Therefore the physical deletion of the RNA and the size of
protein deleted are in agreement with each other and thus NCVP-00
would appear to be a translation product of virtually the entire polio
virus RNA.
To show that the poliovirion RNA is able to direct the synthesis of
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FIG. 3. Comparison of the electrophoretic mobility of virus-specific proteins
induced by poliovirus and DI particles in the presence of amino acid analogs. Cells
infected by standard poliovirus were labeled with [ 3 H)leucine (o--o); cells
infected by DI particles were labeled with [ 14 C)leucine (---•). Both cultures
of cells were exposed to medium in which the arginine, phenylalanine, praline, and
methionine had been replaced by canavanine, p-fluorophenylalanine, azetidine-2carboxylic acid, and ethionine. The proteins labeled in the two cultures were
mixed and analyzed by electrophoresis through 7.2% polyacrylamide gels in the
presence of sodium dodecyl sulfate. The protein "NCVP 00" coelectrophoresed
with a marker of myosin indicating a molecular weight in excess of 200,000.
Migration was from left to right. Reprinted from Cole and Baltimore (1973).

this single, very long polypeptide, use was made of an in vitro cell-free
system derived from mouse ascites cells. By shifting the salt concentra
tion during a 90-minute incubation from the optimum for initiation (90
mM) to the optimum for elongation (150 mM), a significant amount of
protein of the size of NCVP-00 has been made (Villa-Komaroff, 1975;
Villa-Komaroff et al., 1975). When standard RNA was used to program
the system, the longest polypeptide product had the same size as the
NCVP-00 made in the presence of amino acid analogs (Fig. 4). When
the system was programmed by polio DI RNA (Fig. 5), the size of the
longest product was shorter than NCVP-00 by the same amount as the
longest product made in cells infected by polio DI (compare to Fig. 3).
Therefore the same products can be made in vitro using a system
programmed by virion RNA as are made in vivo, and we can conclude
that the virion RNA can act as mRNA.
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FIG. 4. Polyacrylamide gel electrophoresis of the products synthesized in
response to poliovirus RNA in a cell-free extract of mouse ascites cells. The
reaction mixture, containing per milliliter 50 µg of poliovirus RNA and 250 µCi
of [ 35 SJ methionine, was incubated for 15 minutes with 92 mM K + phosphate and
then 105 minutes with 155 mM K +. The products formed were separated by
electrophoresis through a polyacrylamide gel and then submitted to autoradio
graphy. The autoradiogram was scanned with a microdensitometer, and the
pattern is shown in the solid line (--). In a parallel polyacrylamide gel, the
poliovirus-specific proteins made in the presence of amino acid analogs in infected
cells were analyzed (- - -). Migration was from left to right. Unpublished data of
Dr. Lydia Villa-Komaroff.

Because the two major RNA species needed by poliovirus, the virion
RNA and the mRNA, are identical, the replication system of poliovirus
need be only very simple. The existing evidence confirms the simplicity
of the system because only a few RNA species are involved. Figure 6
shows a schematic representation of the types of RNA molecules
involved in poliovirus replication. The incoming "plus" strand syn
thesizes a "minus" strand, which in turn synthesizes a series of "plus"
strands. As we shall see, this simplicity is in marked contrast to the
complexity of other viral replication schemes.
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FIG. 5. Polyacrylamide gel electrophoresis of the products synthesized in
response to DI particle RNA in a cell-free extract of mouse ascites cells. Meth
odology as in Fig. 4 except that the cell-free extract was programmed by DI
particle RNA. Unpublished data by Dr. Lydia Villa-Komaroff.

An important aspect of the scheme shown in Fig. 6 is the poly
1
adenylic acid [poly(A)] found at the 3 -end of poliovirion RNA (Arm
strong et al., 1972; Yogo and Wimmer, 1972; Spector and Baltimore,
1975). It has been shown that the minus strands have poly(U) at their
1
5 -ends (Yogo et al., 1974), and it appears that the poly(U) encodes the
poly(A), and vice versa (Spector and Baltimore, 1975). Cellular mes
1
senger RNAs often have 3 -terminal poly(A), and so poliovirus RNA
would seem to have appropriated a cellular mechanism. However, in
contrast to poliovirus poly(A), cellular poly(A) does not appear to be
encoded in cellular DNA, but rather is added to mRNA or its precursor
by a posttranscriptional mechanism (Brawerman, 1974).
Poliovirus RNA needs its poly(A) for some critical function: removal
of the poly(A) with ribonuclease H plus poly(dT) abolishes the infec
tivity of the RNA (Spector and Baltimore, 1974). The translation of
poly(A)-deficient RNA in a cell-free system is not impaired, however,
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FIG. 6. The poliovirus genetic system. Schematic representation of poliovirus
specific RNA synthesis in the cytoplasm of infected cells.

and so the poly(A) is probably necessary to replication (Spector et al.,
1975). Cellular mRNA has never been shown to replicate; poliovirus
therefore appears to use its poly(A) for a function not performed in the
uninfected cell. This is an interesting example of the appropriation by a
1
virus of a cellular mechanism [the 3 -terminal addition of poly(A)] and
its use for a virus-specific purpose.
III. VESICULAR STOMATITIS VIRUS
Vesicular stomatitis virus (VSV) has an RNA genome consisting of a
single strand of RNA of about 4 X. 10 6 daltons. The key experiment
leading to an understanding of the strategy of VSV was the observation
that the mRNA found a polyribosomes was not the 4 X 10 6 dalton
virion RNA, but was rather a collection of smaller RNAs (Huang et al.,
1970). Sedimentation of the mRNAs separated them into two size
classes: one, a homogeneous RNA sedimenting at 28 S, and the second,
a heterogeneous group of RNAs sedimenting with a peak at about 13 S.
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TABLE I
ANNEALING OF VIRAL MESSENGER RNA WITH
VESICULAR STOMATITIS VIRUS RNAa
% Ribonuclease-resistance when

annealed to
Messenger RNA

No added RNA

VSV RNA

13S
28 S

0.0
0.7

101

99

aAdapted from Huang et al. (1970).

Both of these mRNAs, rather than having the same nucleic acid polarity
as the virion RNA, were complementary to the virion RNA (Table I). If
we define all mRNAs as plus RNAs (Baltimore, 1971), then VSV has a
minus strand genome and, in fact, has become the prototype virus for a
class of viruses now known as the "negative strand viruses." The
discovery that these small RNAs were complementary in base sequence
to that of the virion RNA, led to the idea that there might be an RNA
polymerase in the virion. Otherwise, it was difficult to understand how
infection could start. We therefore assayed disrupted virions for RNA
polymerase activity and found that the virion could synthesize RNA
(Table II) (Baltimore et al., 1970). Furthermore, the RNA made by the
virion would anneal to the virion RNA (Table III). More recently it has
been shown that the RNA made by the virion has the same size and
structure as the mRNA for viral proteins (Moyer and Banerjee, 1975)
and will act as viral mRNA in cell-free systems (Both et al., 1975).
The VSV mRNAs, like cellular mRNAs, have a 3' -terminal poly(A)
sequence (Soria and Huang; 1973; Ehrenfeld and Summers, 1972), and
one can use this sequence to purify the mRNAs away from ribosomal
and transfer RNAs (Rose and Knipe, 1975). Unlike the poly(A) on
poliovirus RNA, the poly(A) on VSV mRNAs is not encoded in the
minus strand (Marshall and Gillespie, 1972). Rather, a posttranscription
. addition of poly(A) occurs. The enzyme responsible for VSV poly(A)
synthesis is present in the virion (Villarreal and Holland, 1973; Banerjee
and Rhodes, 1973).
Using a combination of gel electrophoresis and sucrose gradient
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TABLE II
PROPERTIES OF THE VESICULAR STOMATITIS VIRUS
RNA POLYMERASEa
Systemb

GMP incorporated (nmoles)

Complete
Minus detergent
Minus magnesium
Minus UTP or CTP
Plus ribonuclease

12.4
0.4
<0.2
<0.3
0.5

a Adapted from Baltimore et al. (1970).

b
complete reaction system contained vmons of VSV,
Tris·HCl, MgC12, mercaptoethanol, NaCl, ATP, UTP, CTP,
3
H-GTP, and 0.1% Triton N-101.

sedimentation, the VSV mRNA population has been separated into
four discrete fractions (Rose and Knipe, 1975). There are five proteins
in the virions of VSV, and only these five proteins are evident in
infected cells (Wagner et al., 1972). The existence of four mRNA
classes and five proteins raised the question of which RNAs encode
which proteins.
One of the size classes of RNA is the 28 S RNA; this has been shown
to encode the largest of the VSV proteins using a cell-free protein-syn
thesizing system (Morrison et al., 1974). A similar analysis has shown
TABLE III
ANNEALING OF POLYMERASE PRODUCTS WITH VESICULAR
STOMATITIS VIRUS RNAa
Treatment

% Ribonuclease resistance

Boiled and quickly chilled
Boiled and annealed with VSV-RNA
Boiled and annealed with poliovirus RNA
Boiled and annealed with no added RNA

4.5
94
21
20

a Adapted from Baltimore et al. (1970).
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that two of the three smaller RNA size classes each encodes an individ
ual polypeptide (Knipe et al., 1975; Both et al., 1975). The fourth
RNA size class encodes two polypeptides; because this RNA fraction
consists of molecules only long enough to encode one of the two
proteins whose synthesis it directs, it must consist of two mRNAs that
are so similar that they have been inseparable (Knipe et al., 1975; Both
et al., 1975). It appears, therefore, that the virion RNA of VSV codes
for the synthesis of 5 mRNAs, each of which in turn codes for the
synthesis of a single protein. The concept of multiple complementary
mRNAs made from a single-input RNA is apparently a general mecha
nism for many RNA virsues and is not a peculiarity of VSV (Baltimore,
1971; Fenner et al., 1974).
This method of forming the viral mRNAs is very different from that
of poliovirus and requires that there be two kinds of VSV-specific RNA
synthetic systems rather than the one kind of RNA synthesis which is
utilized by poliovirus (Soria et al., 1974; Perlman and Huang, 1973/74).
For VSV, the process of transcription involves the synthesis of the five
individual mRNAs while the process of replication works more or less
like the poliovirus replication system. Figure 7 shows these two limbs
of the VSV RNA synthetic mechanism; there is extensive evidence
supporting this model (Soria et al., 1974).
IV. RNA TUMOR VIRUSES
RNA tumor viruses have an RNA genome which sediments at 60-70
S, a sedimentation rate much larger than that of either VSV RNA or
poliovirus RNA. Denaturation of the 70 S RNA, however, causes it to
come apart into 35 S RNA molecules, each of which is exactly the same
size as poliovirus RNA (see Green, 1970). Recent data from a number
of laboratories indicate that all the 35 S RNA molecules of a single
virus are identical (see Baltimore, 1975), and therefore the amount of
information in the RNA tumor viruses is about the same as that in
poliovirus.
In spite of the superficial similarity to poliovirus RNA, the strategy of
RNA tumor viruses is very different. The key observation to under
standing this system was the realization that DNA plays a significant
role in the synthesis of RNA tumor viruses. This concept emerged from
work in a number of laboratories during the 1960s (Bader, 1967;
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FIG. 7. Vesicular stomatitis virus RNA synthesis in the cytoplasm of infected
cells. The 40 S RNA, the genome RNA of the virus, is shown covered by the N
protein to form a nucleocapsid. Similarly, its complementary strand, the 40 S plus
RNA, is shown covered by N protein as indicated by the data of Soria et al.
(1974). During VSV transcriptional RNA synthesis, the products are not covered
by the N protein but appear to be "free" RNA. The five transcriptional products
act as mRNA for the synthesis of the five VSV proteins. Reprinted from Soria et
al (1974).

Temin, l-964a,b, 1967, 1970) and was specifically formulated into the
provirus hypothesis by Howard Temin (1964a,b). The provirus hypo
thesis probably received its strongest support from the observation that
the RNA tumor virus genome contains an enzyme able to make a DNA
copy of the viral RNA (Baltimore, 1970; Temin and Mizutani, 1970;
Temin and Baltimore, 1972). This enzyme has been called the reverse
transcriptase (Anonymous, 1970).
The reverse transcriptase, like all DNA polymerases, is a primer-de
pendent DNA polymerase (Baltimore and Smoler, 1971; Smoler et al.,
1971; Kornberg, 1969). It is unable to initiate deoxyribonucleotide
chains on its own, but rather requires a preformed primer on which to
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polymerize the substrate. The enzyme has a number of unique features
that distinguish it from cellular polymerases. One of these is the ease
with which it copies polyribonucleotides; this is most evident using
ribohomopolymers, the most diagnostic of which is poly(C). If poly(C)
and an oligo(dG) primer are provided to the reverse transcriptase along
with dGTP, the enzyme readily polymerizes dGMP to form poly(dG),
and this rapid reaction is virtually diagnostic of the reverse transcriptase
(Baltimore et al., 1973; Sarngadharan et al., 1972). Another unique
feature of the enzyme is that it contains a ribonuclease H activity (an
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FIG. 8. The life cycle of an RNA tumor virus. Based on the present status of
knowledge of the system (Baltimore, 1975), the life cycle of an RNA tumor virus
can be separated into two parts. In the first part the virion attaches to the cell and
somehow allows its RNA along with reverse transcriptase to get into the cell's
cytoplasm. There the reverse transcriptase causes the synthesis of a DNA copy of
the viral RNA. Present evidence indicates that a fraction of the DNA can be
recovered as closed, circular DNA (Varmus et al., 1974; Gianni et al., 1975), and
it is presumably that form which integrates into the cellular DNA. Once the
proviral DNA is integrated into cellular DNA, it can then be expressed by the
normal process of transcription. The two types of product that have been
characterized are new virion RNA and mRNA. Much of the mRNA that specifies
the sequence of viral protein is of the same length as the virion RNA, but there
may also be shorter mRNAs. The virus-specific proteins have two known func
tions: one is the transformation of cells that occurs when a sarcoma virus infects a
fibroblast, the second is to provide the protein for new virion production.
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enzyme activity able to degrade the RNA portion of a DNA-RNA
hybrid) (Moiling et al., 1971). No other DNA polymerase is known to
contain a ribonuclease H activity, although Escherichia coli DNA poly
merase I can carry out a similar type of reaction (Baltimore and Smoler,
1972).
A third very unique feature of the avian RNA tumor virus reverse
transcriptase has recently come to light. The enzyme contains a specific
binding site for tRNA Trp (Panet et al., 1975) and it appears that this
binding site is utilized by the enzyme for the initiation of copying of
the 70 S RNA (Dahlberg et al., 1974).
The basic strategy of RNA tumor viruses therefore appears to be the
utilization of the reverse transcriptase in the virion to make a DNA
copy, which can then integrate into cellular DNA and act like a cellular
gene. Figure 8 shows schematically the life cycle of RNA tumor viruses
as we know it today.
The life cycle of RNA tumor viruses allows them to have two
methods of spreading within an animal population. The whole cycle
shown in Fig. 8 provides a mechanism for infectious spread of the virus
from cell to cell or from animal to animal. Because the proviral DNA is
integrated into the cellular DNA, spreading of virus by inheritance is
possible. In fact, after a cell is infected, all the cell's progeny receive the
virus by inheritance. Animals also receive virus by inheritance, and, in
one case at least, the AKR mouse, viral information has been rigorously
shown to reside at a single genetic locus and to segregate in genetic
crosses as a simple Mendelian locus (Rowe et al., 1972; Chattopadhyay
et al., 1974, 1975).
V. CONCLUSION
It is evident that the superficial similarity of the RNAs in the virions
of poliovirus, VSV, and RNA tumor viruses is misleading. The three
types of viruses use very different strategies for infecting cells. The
unraveling of these strategies has come from a series of key observa
tions: the infectivity of poliovirus RNA, the complementary mRNAs of
VSV, and the reverse transcriptase of RNA tumor viruses.
The two lytic viruses, polio and VSV, sharply contrast with the RNA
tumor viruses. The lytic viruses provide the cell with a completely new
system for the replication and transcription of RNA. They establish, in
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the cytoplasm of the infected cell, RNA synthetic systems that supply
to the cell's ribosomes large amounts of virus-specific RNA. The pro
ducts encoded by this RNA rapidly take over the cell and as the large
quantities of viral products build up in the cell, new virions are formed
and the cell dies. The RNA tumor viruses, on the other hand, insinuate
themselves into the cell's genetic system and maintain themselves as
part of the cell without killing the cell, in fact without seriously
perturbing the cell's metabolism.
These two styles of living for viruses, the lytic style and the integra
tive style, are reflected in the way these two types of viruses maintain
themselves in the environment. Polio and VSV must continually infect
new animals to propagate themselves. Their life is a neverending cycle
of first a few days multiplying in one animal and then a few days
multiplying in another animal. Breaking this cycle would completely
eliminate the virus from the environment and in fact, the vaccination
of the world's population against certain viruses may soon lead to the
complete elimination of such viruses from the environment. (We need
not worry about the extinction of those viruses, however, because we
can maintain them in our laboratories, which are relatively inexpensive
and effective zoos for the maintenance of viral genetic information for
the future.)
RNA tumor viruses, in contrast to lytic viruses, can use their ability
to act as DNA in order to get into the germ line of animals. There they
can maintain themselves for very long periods of time without any
apparent effect on the animal. Once in the germ line of a species, the
viruses will be passed from parent to offspring probably for millions of
years. I would guess, although many will disagree with me, that in the
germ line of animals many RNA tumor viruses have a negligible effect
on the fitness of the animal and therefore are neither selected for nor
against by evolution. In such a situation, after many rounds of duplica
tion the viruses will begin to accumulate mutations and it seems evident
that unless they submitted themselves to the rigors of evolutionary
selection occasionally they would become extinct. Therefore it is not .
surprising that the viruses can also maintain a horizontal mode of
infection under certain conditions, moving from animal to animal just
like a lytic virus; in fact, we should not forget that there are lytic
viruses that use reverse transcription as a central part of their life cycle
(Temin and Baltimore, 1972). Once the viruses have been invigorated
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by evolution, they can again go back into the germ line and maintain a
covert life for numerous generations. Disturbed only by an occasional
mutation, they will be faithfully transmitted from parent to offspring.
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